Dividend growth investing builds long-term wealth for retirement by focusing on companies that consistently increase payouts.

Novo Nordisk just got a big win from the FDA, and it could change the weight-loss medicine industry again.

Novo Nordisk’s oral Wegovy wins FDA approval, outperforming rivals in weight loss. Discover why NVO stock is undervalued now.

From autonomous robotaxis, to blind box and nostalgia marketing here are 5 of the most innovative business moves and trends ...

In response to the threats, European governments raced to strike deals. The UK secured a zero tariff arrangement in return ...

Here are five healthcare themes to watch next year, and which stocks stand to benefit. Key names to watch include Eli Lilly, ...

The rise of China and India, combined with protectionist pressure from the Trump administration, is redrawing the global map ...